7Baggers
 William Blair Downgrades MiNK Therapeutics(INKT.US) to Hold Rating  富途牛牛 Tue, 30 Sep 2025 04:20:37 GMT
 MiNK Therapeutics appoints trauma expert Dr. John Holcomb to board  Investing.com Mon, 29 Sep 2025 17:43:52 GMT
 MiNK Therapeutics Appoints Dr. John Holcomb as Director  TipRanks Mon, 29 Sep 2025 13:53:56 GMT
 MiNK Therapeutics appoints John Holcomb to board of directors  TipRanks Mon, 29 Sep 2025 12:06:54 GMT
 mink therapeutics (nasdaq:inkt) shares down 0.9% - what's next?  MarketBeat Sat, 20 Sep 2025 09:56:21 GMT
 published on: 2025-09-19 10:42:21  خودرو بانک Fri, 19 Sep 2025 07:13:12 GMT
 published on: 2025-09-19 01:53:11  خودرو بانک Thu, 18 Sep 2025 22:25:55 GMT
 mink therapeutics (nasdaq:inkt) shares down 0.9% – should you sell?  Defense World Tue, 16 Sep 2025 07:27:52 GMT
 published on: 2025-09-14 11:55:22  newser.com Sun, 14 Sep 2025 16:55:22 GMT
 published on: 2025-08-28 06:24:31  Newser Thu, 28 Aug 2025 11:24:31 GMT
 mink therapeutics cuts q2 cash use 31%  AOL.com Sat, 23 Aug 2025 08:25:07 GMT
 new strong sell stocks for august 22nd  sharewise.com Sat, 23 Aug 2025 01:03:48 GMT
 new strong sell stocks for august 22nd  Barchart.com Fri, 22 Aug 2025 07:00:00 GMT
 mink therapeutics cuts q2 cash use 31%  AOL.com Wed, 20 Aug 2025 12:54:31 GMT
 mink therapeutics shares rise after hc wainwright upgrade  MarketScreener Fri, 15 Aug 2025 07:00:00 GMT

MiNK Therapeutics, Inc.
(NASDAQ:INKT) 

INKT stock logo

MiNK Therapeutics, Inc. operates as a clinical stage biopharmaceutical company engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T cell therapies to treat cancer and other immune-mediated diseases. The company was founded in 2017 and ...

Founded: 2017
CEO: Jennifer Buell  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends